期刊
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
卷 1832, 期 6, 页码 826-836出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2013.02.020
关键词
Prion; Transmissible spongiform encephalopathy; Fibrillization; Protein-cleavage
资金
- Biotechnology and Biological Sciences Research Council, UK
- Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/A/00001651, BBS/E/D/05241340, BBS/E/D/05241338, BBS/E/D/20251968, BS516875] Funding Source: researchfish
- BBSRC [BBS/E/D/20251967, BBS/E/A/00001651, BBS/E/D/05241340, BBS/E/D/05241338, BBS/E/D/20251968] Funding Source: UKRI
Expression of the cellular prion protein (PrPC) is crucial for the development of prion diseases. Resistance to prion diseases can result from reduced availability of the prion protein or from amino acid changes in the prion protein sequence. We propose here that increased production of a natural PrP alpha-cleavage fragment, C1, is also associated with resistance to disease. We show, in brain tissue, that ARR homozygous sheep, associated with resistance to disease, produced PrPC comprised of 25% more C1 fragment than PrPC from the disease-susceptible ARQ homozygous and highly susceptible VRQ homozygous animals. Only the C1 fragment derived from the ARR allele inhibits in-vitro fibrillisation of other allelic PrPC variants. We propose that the increased a-cleavage of ovine ARR PrPC contributes to a dominant negative effect of this polymorphism on disease susceptibility. Furthermore, the significant reduction in PrPC beta-cleavage product C2 in sheep of the ARR/ARR genotype compared to ARQ/ARQ and VRQ/VRQ genotypes, may add to the complexity of genetic determinants of prion disease susceptibility. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据